A Cost Minimization Comparison of Two Surfactants—Beractant and Poractant alfa—Based Upon Prospectively Designed, Comparative Clinical Trial Data

OBJECTIVES: To compare the pharmacoeconomic profiles of beractant (Survanta(®), Ross Laboratories, Columbus, Ohio) and poractant alfa (Curosurf(®), DEY LP, Napa, CA) via a cost-minimization analysis. METHODS: This analysis was based upon clinical data from two previously published studies (Speer C,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marsh, Wallace, Smeeding, James, York, John M., Ramanathan, Rangasamy, Sekar, Krishnamurthy
Formato: Artigo
Lenguaje:Inglês
Publicado: Pediatric Pharmacy Advocacy Group 2004
Materias:
Clinical Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3469128/
https://ncbi.nlm.nih.gov/pubmed/23118698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-9.2.117
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares